The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Sato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,372
Shimizu, J., Yamazaki, S., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5211 · Cited by 1,491
Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., & Nakayama, E. (1999) · PubMed · Cited by 1,062
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., & Iacopetta, B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 991
Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.102 · Cited by 897
Helping the CD8+ T-cell response
Bevan, M. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1413 · Cited by 797
The role of CD4+ T cell responses in antitumor immunity
Pardoll, D. M., & Topalian, S. L. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80228-8 · Cited by 672
Nakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H., & Ohtani, H. (2001) · PubMed · Cited by 639
Greenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay, N. E. H., Mosseri, V., Laccourreye, O., Bruneval, P., Fridman, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1886 · Cited by 598
Fukunaga, A., Miyamoto, M., Cho, Y., Murakami, S., Kawarada, Y., Oshikiri, T., Kato, K., Kurokawa, T., Suzuoki, M., Nakakubo, Y., et al. (2004) · Pancreas · doi:10.1097/00006676-200401000-00023 · Cited by 532
Sharma, P., Shen, Y., Wen, S., Yamada, S., Jungbluth, A. A., Gnjatic, S., Bajorin, D. F., Reuter, V. E., Herr, H., Old, L. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611618104 · Cited by 526
CD4 T Cells and Their Role in Antitumor Immune Responses
Toes, R. E. M., Ossendorp, F., Offringa, R., & Melief, C. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.753 · Cited by 508
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
Schumacher, K., Haensch, W., Röefzaad, C., & Schlag, P. M. (2001) · PubMed · Cited by 503
Piersma, S. J., Jordanova, E. S., van Poelgeest, M. I. E., Kwappenberg, K. M. C., van der Hulst, J. M., Drijfhout, J. W., Melief, C. J. M., Kenter, G. G., Fleuren, G. J., Offringa, R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3388 · Cited by 414
Leffers, N., Gooden, M. J. M., de Jong, R. A., Hoogeboom, B.-N., ten Hoor, K. A., Hollema, H., Boezen, H. M., van der Zee, A. G. J., Daemen, T., & Nijman, H. W. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0583-5 · Cited by 402
Human CD4+CD25+ regulatory T cells
Baecher-Allan, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.12.005 · Cited by 385
TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response
Baniyash, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1434 · Cited by 344
Costimulation of T cells for tumor immunity
Chen, L., Linsley, P. S., & Hellström, K. E. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90262-j · Cited by 315
Tumor-infiltrating T lymphocytes: Friends or foes?
Yu, P., & Fu, Y.-X. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700389 · Cited by 299
Unitt, E., Marshall, A., Gelson, W., Rushbrook, S. M., Davies, S., Vowler, S. L., Morris, L. S., Coleman, N., & Alexander, G. J. M. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.027 · Cited by 257
Wakabayashi, O., Yamazaki, K., Oizumi, S., Hommura, F., Kinoshita, I., Ogura, S., Dosaka‐Akita, H., & Nishimura, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01392.x · Cited by 252
PRALL, F. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.01.022 · Cited by 226
Intratumoral CD8+ T Lymphocytes as a Prognostic Factor of Survival in Endometrial Carcinoma
Kondratiev, S., Sabo, E., Yakirevich, E., Lavie, O., & Resnick, M. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0732-3 · Cited by 224
van der Burg, S. H., Piersma, S. J., de Jong, A., van der Hulst, J. M., Kwappenberg, K. M. C., van den Hende, M., Welters, M. J. P., Van Rood, J. J., Fleuren, G. J., Melief, C. J. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704672104 · Cited by 217
Tanaka, H., Tanaka, J., Kjaergaard, J., & Shu, S. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200205000-00003 · Cited by 206
Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms
Ruffini, E., Asioli, S., Filosso, P. L., Lyberis, P., Bruna, M. C., Macrì, L., Daniele, L., & Oliaro, A. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.10.067 · Cited by 205
Chiba, T., Ohtani, H., Mizoi, T., Naito, Y., Sato, E., Nagura, H., Ohuchi, A., Ohuchi, K., Shiiba, K., Kurokawa, Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602201 · Cited by 201
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
Tomšová, M., Melichar, B., Sedláková, I., & Šteiner, I. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.10.016 · Cited by 186
Baskar, S., Glimcher, L., Nabavi, N., Jones, R. T., & Ostrand-Rosenberg, S. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.619 · Cited by 182
Use of tumour-responsive T cells as cancer treatment
Disis, M. L., Bernhard, H., & Jaffee, E. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60404-9 · Cited by 164
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival
Gjerdrum, L. M., Woetmann, A., Odum, N., Burton, C. M., Rossen, K., Skovgaard, G. L., Ryder, L. P., & Ralfkiaer, E. (2007) · Leukemia · doi:10.1038/sj.leu.2404913 · Cited by 158
Grabenbauer, G. G., Lahmer, G., Distel, L. V., & Niedobitek, G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2434 · Cited by 142
Nishikawa, H., Kato, T., Tawara, I., Takemitsu, T., Saito, K., Wang, L., Ikarashi, Y., Wakasugi, H., Nakayama, T., Taniguchi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503852102 · Cited by 110
Sheu, B., Hsu, S.-M., Ho, H., Lin, R., Torng, P., & Huang, S. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1537::aid-cncr21>3.0.co;2-d · Cited by 107
Sasaki, A., Tanaka, F., Mimori, K., et al. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.08.008 · Cited by 101
Monnier‐Benoit, S., Mauny, F., Riethmuller, D., Guerrini, J.-S., Căpîlna, M. E., Felix, S. A., Seillès, E., Mougin, C., & Prétet, J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.11.039 · Cited by 100
Nedergaard, B. S., Ladekarl, M. B., Thomsen, H. F., Nyengaard, J. R., & Nielsen, K. N. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604001 · Cited by 88
Yoshioka, T., Miyamoto, M., Cho, Y., Ishikawa, K., Tsuchikawa, T., Kadoya, M., Li, L., Mishra, R., Ichinokawa, K., Shoji, Y., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604294 · Cited by 67
Prall, F., Dührkop, T., Weirich, V., Ostwald, C., Nizze, H., & Barten, M. (2004) · Pathology - Research and Practice · doi:10.1016/s0344-0338(04)80716-7 · Cited by 44
New insights into tumor-host interactions in lymphoma metastasis
Umansky, V., Schirrmacher, V., & Rocha, M. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00210630 · Cited by 29
Santin, A. D., Bellone, S., Palmieri, M., Bossini, B., Roman, J. J., Cannon, M. J., Bignotti, E., Canè, S., & Pecorelli, S. L. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00083-0 · Cited by 28
Critical role for CD8 + FoxP3 + regulatory T cells in colon cancer immune response in humans
Sobhani, I., & Gouvello, S. L. (2009) · Gut · doi:10.1136/gut.2008.175521 · Cited by 20
T Cells a Boon for Colon Cancer Prognosis
Couzin, J. (2006) · Science · doi:10.1126/science.313.5795.1868b · Cited by 11
Shah, W., Hongwei, C., Jin, Z., Lifang, D., Jun, Y., & Yili, W. (2009) · Clinical Oncology · doi:10.1016/j.clon.2009.09.003 · Cited by 8
Self-citation
Cited by
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Schürch, C. M., Bhate, S. S., Barlow, G. L., Phillips, D. J., Noti, L., Zlobec, I., Chu, P., Black, S., Demeter, J., McIlwain, D. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.005 · Cited by 1,064
Shang, B., Liu, Y., Jiang, S.-J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep15179 · Cited by 985
Inflammatory Response Mechanisms of the Dentine–Pulp Complex and the Periapical Tissues
Galler, K. M., Weber, M., Korkmaz, Y., Widbiller, M., & Feuerer, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031480 · Cited by 455
deLeeuw, R. J., Kost, S. E., Kakal, J. A., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3216 · Cited by 437
Metadata
- Authors
- Shah, W., Yan, X., Jing, L., Zhou, Y., Chen, H., & Wang, Y.
- Venue
- Cellular & Molecular Immunology
- Published
- 2010-11-22
- Volume
- 8
- Issue
- 1
- Pages
- 59-66
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- OpenAlex
- W1984650310
- Cited by
- 267
- References
- 50
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.